Jump to main content
Jump to site search

Issue 7, 2016
Previous Article Next Article

Iron-dependent lysosomal dysfunction mediated by a natural product hybrid

Author affiliations

Abstract

Artesumycin is a fluorescent hybrid of the natural products marmycin A and artemisinin. It was designed to combine the lysosomotropic properties of the angucycline and the iron-reactive capacity of the endoperoxide to target the lysosomal compartment of cancer cells. Herein, we show that artesumycin inhibits cancer cell proliferation in an iron-dependent manner and chemically fragments in vitro in the presence of redox-active iron(II). Visual detection of artesumycin by fluorescence microscopy provided substantial evidence that the small molecule selectively targets lysosomes. This original approach based on a fluorescent and iron-reactive probe represents a powerful strategy for initiating and, concomitantly, visualizing lysosomal dysfunction in human cells.

Graphical abstract: Iron-dependent lysosomal dysfunction mediated by a natural product hybrid

Back to tab navigation

Supplementary files

Publication details

The article was received on 08 Nov 2015, accepted on 24 Nov 2015 and first published on 24 Nov 2015


Article type: Communication
DOI: 10.1039/C5CC09255H
Author version
available:
Download author version (PDF)
Chem. Commun., 2016,52, 1358-1360

  •   Request permissions

    Iron-dependent lysosomal dysfunction mediated by a natural product hybrid

    A. Mariani, T. T. Mai, E. Zacharioudakis, A. Hienzsch, A. Bartoli, T. Cañeque and R. Rodriguez, Chem. Commun., 2016, 52, 1358
    DOI: 10.1039/C5CC09255H

Search articles by author

Spotlight

Advertisements